Critical illness myopathy after COVID-19
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved..
This paper describes a patient who developed diffuse and symmetrical muscle weakness after a long stay in the intensive care unit (ICU) due to coronavirus disease 2019 (COVID-19). The patient underwent a neurophysiological protocol, including nerve conduction studies, concentric needle electromyography (EMG) of the proximal and distal muscles, and direct muscle stimulation (DMS). Nerve conduction studies showed normal sensory conduction and low-amplitude compound muscle action potentials (CMAPs). EMG revealed signs of myopathy, which were more pronounced in the lower limbs. The post-DMS CMAP was absent in the quadriceps and of reduced amplitude in the tibialis anterior muscle. Based on these clinical and neurophysiological findings, a diagnosis of critical illness myopathy was made according to the current diagnostic criteria. Given the large number of patients with COVID-19 who require long ICU stays, many are very likely to develop ICU-acquired weakness, as did the patient described here. Health systems must plan to provide adequate access to rehabilitative facilities for both pulmonary and motor rehabilitative treatment after COVID-19.
| Errataetall: |
CommentIn: Int J Infect Dis. 2020 Dec;101:56. - PMID 33002612 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:99 |
|---|---|
| Enthalten in: |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases - 99(2020) vom: 10. Okt., Seite 276-278 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bagnato, Sergio [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Case Reports |
|---|
| Anmerkungen: |
Date Completed 27.10.2020 Date Revised 10.01.2021 published: Print-Electronic CommentIn: Int J Infect Dis. 2020 Dec;101:56. - PMID 33002612 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ijid.2020.07.072 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM313385149 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM313385149 | ||
| 003 | DE-627 | ||
| 005 | 20231225150447.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijid.2020.07.072 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1044.xml |
| 035 | |a (DE-627)NLM313385149 | ||
| 035 | |a (NLM)32763444 | ||
| 035 | |a (PII)S1201-9712(20)30606-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bagnato, Sergio |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Critical illness myopathy after COVID-19 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.10.2020 | ||
| 500 | |a Date Revised 10.01.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Int J Infect Dis. 2020 Dec;101:56. - PMID 33002612 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved. | ||
| 520 | |a This paper describes a patient who developed diffuse and symmetrical muscle weakness after a long stay in the intensive care unit (ICU) due to coronavirus disease 2019 (COVID-19). The patient underwent a neurophysiological protocol, including nerve conduction studies, concentric needle electromyography (EMG) of the proximal and distal muscles, and direct muscle stimulation (DMS). Nerve conduction studies showed normal sensory conduction and low-amplitude compound muscle action potentials (CMAPs). EMG revealed signs of myopathy, which were more pronounced in the lower limbs. The post-DMS CMAP was absent in the quadriceps and of reduced amplitude in the tibialis anterior muscle. Based on these clinical and neurophysiological findings, a diagnosis of critical illness myopathy was made according to the current diagnostic criteria. Given the large number of patients with COVID-19 who require long ICU stays, many are very likely to develop ICU-acquired weakness, as did the patient described here. Health systems must plan to provide adequate access to rehabilitative facilities for both pulmonary and motor rehabilitative treatment after COVID-19 | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Direct muscle stimulation | |
| 650 | 4 | |a Electromyography | |
| 650 | 4 | |a ICU-acquired weakness | |
| 650 | 4 | |a Rehabilitation | |
| 650 | 4 | |a SARS-CoV-2 | |
| 700 | 1 | |a Boccagni, Cristina |e verfasserin |4 aut | |
| 700 | 1 | |a Marino, Giorgio |e verfasserin |4 aut | |
| 700 | 1 | |a Prestandrea, Caterina |e verfasserin |4 aut | |
| 700 | 1 | |a D'Agostino, Tiziana |e verfasserin |4 aut | |
| 700 | 1 | |a Rubino, Francesca |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases |d 1998 |g 99(2020) vom: 10. Okt., Seite 276-278 |w (DE-627)NLM094730857 |x 1878-3511 |7 nnns |
| 773 | 1 | 8 | |g volume:99 |g year:2020 |g day:10 |g month:10 |g pages:276-278 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijid.2020.07.072 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 99 |j 2020 |b 10 |c 10 |h 276-278 | ||